C
Centese
Develops cardiothoracic post-operative medical equipment for post-operative surgical care and patient monitoring
About Centese
Centese Inc. is a medical technology company specializing in advanced digital solutions for cardiothoracic surgery. Their flagship product, Thoraguard, revolutionizes post-operative care by providing precise data monitoring and automated chest tube clearance. This innovation aims to enhance clinical decision-making and patient safety, ultimately improving outcomes and reducing costs. Centese serves healthcare providers and hospitals in the cardiothoracic surgery market. Their business model revolves around selling and supporting their digital systems, generating revenue through product sales and service contracts.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Omaha, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 75.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Critical medical care, Hard Tech, remote health monitoring, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2023 | $15M | $60M | MedTech VP | ↗ |
| SERIES A✓Equity / VC | Aug 2019 | $2M | $8M | Invest Nebraska | — |
Growth signals
Latest recorded traffic for Centese is 220 monthly website visits, down 63.3% over the last three months. Centese's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A2 investors entered at this stage
Invest Nebraska
MedTech VP
Other known investors8 additional known investors
Brock Smith
Innovation In Motion
Nebraska Angel Network
New York Angels
Nucleate
Proven Ventures
Scientific Health Development Partners
The Startup Collaborative
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Centese on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Centese’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






